Synergy Pharmaceuticals: Soars on licensing agreement

Cipher Pharmaceuticals

02/03/2018 17:06

** Drugmaker's shares  SGYP.O  up 16.5 pct at $2.04
    ** To get $5 mln upfront in addition to milestone payments
and royalties, from licensing agreement with Canada-based
drugmaker Cipher Pharmaceuticals Inc  CPH.TO  for its
constipation treatment, Trulance  urn:newsml:reuters.com:*:nNRA5nix30
    ** SGYP will manufacture and supply finished product to CPH
    ** Stock had fallen 16 pct YTD

 (Reporting by Mrinalini Krothapalli)
 ((mrinalini.krothapalli@thomsonreuters.com;))